Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-25

Clinical Trial Update: Safety and Efficacy of Evolocumab in Ischemic Stroke [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating safety and efficacy of evolocumab in patients with acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Evolocumab (evolocumab)

Snippet

Sponsor: Second Affiliated Hospital of Guangxi Medical University | Conditions: Ischemic Stroke, Acute | Phase 4 | Status: UNKNOWN